PR Newswire is a global leader in communications and marketing services, enabling organizations to connect and engage with their target audiences worldwide.
Recent Articles By The Author
Skills® For Autism Wins Gold At The Learning Technologies Awards
Web-based software tool by SKILLS Global supports learning of children and adolescents with autism
CSL Behring Presents New Phase III Analysis Of IDELVION® For Hemophilia B At The 2016 American Society Of Hematology Annual Meeting
- Analysis of clinical trial efficacy results and estimated factor IX levels suggests that patients who maintain factor IX activity levels above 5 and 10 percent have significantly reduced bleeding risk
Data At ASH 2016 Show Strong, Lasting Efficacy Of IMBRUVICA® (ibrutinib) Through Five Years Of Treatment For Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
89% of study patients, including those with high-risk CLL/SLL, responded to therapy